Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms

NCT00449813 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00449813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00449813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2007
Completion date
November 30, 2008
Enrollment
40 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease, non-erosive reflux disease